139 results
Page 3 of 7
424B3
xyvayfjpn3s4
2 Aug 13
Prospectus supplement
12:00am
424B5
pqwd4 zm1qrpizvt
3 Jun 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
d7m4gc
7 Jan 13
BioTime Signs Definitive Agreement With Geron Regarding Stem Cell Assets
12:00am
DEFA14A
cm1n0thy3tskp
7 Jan 13
Additional proxy soliciting materials
12:00am
DFAN14A
1faw1t90yw54jn
7 Jan 13
Additional proxy materials by non-management
12:00am
8-K
EX-99.1
1xhph
15 Nov 12
BioTime Announces Non-Binding Letter of Intent with Geron Regarding Stem Cell Assets
12:00am
8-K
EX-99.1
ja79b hyudc1uk3wodbh
23 May 12
BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards® Version 3.08
12:00am
8-K
EX-99.1
b9j3jf0tlxaolz hkhq
22 May 12
BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human Diseases
12:00am
8-K
EX-99.1
xzsdfkl75q88d kgu
21 May 12
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
ip8hz
14 May 12
Regulation FD Disclosure
12:00am
8-K
EX-99.4
o5lf7qdm5yn
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.6
dsam0g vj
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am